Hodgkin-Lymphom: Shared Decision Making als Schlüssel zur Patient:innenzentrierung
摘要
Shared decision-making (SDM) is a structured process in which patients and healthcare professionals make decisions together based on scientific evidence and individual preferences. Healthcare professionals contribute their professional expertise, whilst patients bring their values, life circumstances, and goals to the discussion. Shared decision-making is regarded as the gold standard for patient information. It can improve the quality of care by reducing unnecessary treatments and increasing the use of appropriate therapies.
The “Making SDM a Reality” project demonstrated that SDM can be successfully and sustainably implemented in a university hospital, particularly through training, decision-making tools and patient involvement. In oncology, SDM is particularly important, as treatment decisions often have a significant impact on quality of life and long-term outcomes. In Hodgkin’s lymphoma, the particular challenge lies in balancing a high chance of cure against potential long-term side effects. SDM makes it possible to make such trade-offs transparent and to incorporate individual priorities into treatment decisions. At the same time, there are practical challenges such as time pressure, complex information, emotional strain and structural barriers within the healthcare system. Overall, SDM promotes patient-centred care, strengthens autonomy and can lead to better, individually tailored treatments in the long term.